1. Home
  2. RDWR vs VOR Comparison

RDWR vs VOR Comparison

Compare RDWR & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Radware Ltd.

RDWR

Radware Ltd.

HOLD

Current Price

$37.17

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$20.64

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDWR
VOR
Founded
1996
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
RDWR
VOR
Price
$37.17
$20.64
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$30.50
★ $39.00
AVG Volume (30 Days)
282.6K
★ 767.0K
Earning Date
10-28-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.09
N/A
Revenue Next Year
$7.92
N/A
P/E Ratio
$59.76
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.68
$6.50
52 Week High
$35.70
$26.76

Technical Indicators

Market Signals
Indicator
RDWR
VOR
Relative Strength Index (RSI) 74.74 56.21
Support Level $26.53 $17.35
Resistance Level N/A $24.23
Average True Range (ATR) 1.96 1.15
MACD 0.74 0.24
Stochastic Oscillator 85.67 94.33

Price Performance

Historical Comparison
RDWR
VOR

About RDWR Radware Ltd.

Radware Ltd is a provider of application security and delivery solutions for multi-cloud environments. Its solutions secure the digital experience by providing infrastructure, application, and network protection and availability services to companies globally. Its solutions are deployed by, among others, enterprises, carriers, and cloud service providers. The company offers solutions in two main categories: Products offers a range of cloud-based security-as-a-service subscriptions, on-premises hardware and software products, and product subscriptions (or a combination of these) to customers; and Services offers managed services, professional services, technical support and training and certification to customers and partners.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: